Hyperhomocysteinemia: A risk factor for arterial and venous thrombotic disease
- 1 December 1997
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical and Laboratory Research
- Vol. 27 (2) , 139-144
- https://doi.org/10.1007/bf02912449
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Methylenetetrahydrofolate Reductase Polymorphism, Plasma Folate, Homocysteine, and Risk of Myocardial Infarction in US PhysiciansCirculation, 1996
- Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.Journal of Clinical Investigation, 1996
- Age and Thrombolytic TherapyCirculation, 1996
- Prevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive DiseaseAnnals of Internal Medicine, 1995
- Hyperhomocysteinemia and Low Pyridoxal PhosphateCirculation, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosisThrombosis Research, 1993
- Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.Circulation, 1993